Swift Biosciences

The two companies hope to provide translational researchers a faster, more comprehensive option for the design and validation of Accel-Amplicon panels.

The sample prep technologies firm intends to use the funding to expand its commercial channels, among other things.

A team from Mount Sinai and Swift Biosciences used targeted sequencing to detect cancer mutations in uterine lavage fluid.

The partners plan to improve yields from small input samples and provide better sequencing libraries.

Both partners believe the agreement will help expand the scope of their services and give them additional markets for their products.  

The companies will combine their technologies to create workflows for the next-generation sequencing of tumor cells obtained from FFPE samples. 

Pages

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.